WEBINAR – TUBERCULOSIS DIAGNOSTICS
On 6th March 2017, European AIDS Treatment Group and Treatment Action Group (TAG) have jointly organized the webinar on TB Diagnostics.
Moderator: Evgenia Maron
Ruth McNerney, University of Cape Town – TB Diagnostics
Erika Lessem, Treatment Action Group – Advocating for better TB diagnosis
Documents for the webinar
Tuberculosis Diagnostics in 2015: LaTuberculosis Diagnostics in 2015: Landscape,
Priorities, Needs, and Prospects
STARD checklist for the reporting ofSTARD checklist for the reporting of studies of diagnostic accuracy.
First official version, January 2003.
Slide set II - Towards Good Review PSlide set II - Towards Good Review Practice: a training manual for the review of clinical performance of in vitro diagnostic medical devices
Review - New tuberculosis diagnosticReview - New tuberculosis diagnostics and rollout - Ruth McNerney, Jane Cunningham, Pamela Hepple, Alimuddin Zumla
Improving access to new diagnosticsImproving access to new diagnostics through
harmonised regulation: priorities for action Authors: Ruth
Impact of the Xpert MTB/RIF diagnostImpact of the Xpert MTB/RIF diagnostic test for tuberculosis in countries with a high burden of disease
Emerging technologies in point-of-caEmerging technologies in point-of-care molecular diagnostics for resourcelimited settings
Evaluation of diagnostic tests for iEvaluation of diagnostic tests for infectious diseases: general principles
WEBINAR – TUBERCULOSIS TREATMENT
On 13th March 2017, European AIDS Treatment Group and Treatment Action Group (TAG) have jointly organized the webinar on TB Treatment.
Moderator: Evgenia Maron, EATG TB Portfolio Coordinator
Jennifer Hughes, Médecins Sans Frontières (MSF):
Experience of treating multi-drug-resistant and extensively drug-resistant TB and using the new drugs
Erica Lessem, Treatment Action Group:
Advocating for improved multi-drug-resistant TB treatment
Dr Jenny Hughes, a TB doctor in South Africa working with Doctors Without Borders (MSF), graduated from Cardiff University in Wales in 2005. A few years later, she moved to South Africa to gain experience in a different healthcare setting. Witnessing first-hand the devastating effects of TB on impoverished communities is what ignited her passion to treat patients suffering from this curable but largely neglected disease. Since 2010 she has worked in Khayelitsha, Western Cape, where MSF runs a strengthened regimen programme for drug-resistant TB patients that incorporates new drugs into their treatment.
As Director of theTB/HIV Project at Treatment Action Group (TAG), Erica Lessem advocates for improved services and technologies to prevent, diagnose, and treat TB and HIV. In this role, Erica supports research activists across the world, and works closely with developers and policymakers to catalyze TB research and ensure that it responds to the needs of affected communities. Previously, Erica worked on HIV behavioral research studies, supported efforts to end sex trafficking in South Asia, volunteered for the Baltimore CityNeedle Exchange Program, was a grant writer for the TB Alliance, conducted press relations as an Urban Fellow in the New York City Department of Health and Mental Hygiene, and helped create the Republic of Georgia’s first peer support group for breast cancer survivors. Erica received Bachelor of Arts in Spanish and Psychology from Georgetown University, and her Master of Public Health as a Sommer Scholar at the Johns Hopkins Bloomberg School of Public health.